Chronic Disease

Stemming the Rising Tide of Insulin Prices

September 16, 2021

States are putting caps on prices, and Semglee, the first interchangeable biosimilar in the United States, may exert some downward pressure.

Listen to Your Body and Heart. Avoiding Doctor Visits Won't Stop Potential Disease.

August 17, 2021

Many people ignored heart disease signs and symptoms during the COVID-19 pandemic — sometimes with grave consequences.

Specialists are Testing the Value-based Care Waters

July 21, 2021

After having thrived in a fee-for-service healthcare system, can chronic disease specialists be enticed to switch?

Psychedelics Take a Long, Strange Trip to Respectability

June 09, 2021

Research and investment are increasing into psilocybin and MDMA as treatments for several mental health disorders.

3 Takeaways About Managing the Cost of MS

May 21, 2021

Multiple sclerosis is dependably among the most expensive chronic diseases to treat, but there are ways to reduce the size of the bill.

Knowing SDOH is Good Medicine

April 26, 2021

Paying attention to the social determinants of health may be a powerful way of improving cardiovascular outcomes.

Eosinophilic Asthma Severe but Now More Manageable

April 23, 2021

Corticosteroids are a mainstay but the introduction of biologics has transformed the management of this severe form of asthma.

MHE Talks: The Greater Need of Patient Access for Patients with Multiple Sclerosis

February 23, 2021

In this latest episode of MHE Talks: Improving Patient Access podcast, Dennis Bourdette, M.D., professor emeritus of neurology in the School of Medicine at the Oregon Health & Science University, spoke with Peter Wehrwein, senior editor of MHE. Bourdette, a nationally recognized expert on multiple sclerosis, discussed step therapy, tiers, insurance approvals and the need for greater communication between physicians and insurers.